BC Extra | Jul 31, 2017
Company News

Management tracks: Aeterna, Microbix, Dimension

Cancer and endocrinology company Aeterna Zentaris Inc. (TSX:AEZS; NASDAQ:AEZS) named Michael Ward CEO. He was chief compliance and legal officer and corporate secretary of Sagent Pharmaceuticals Inc. , which Nichi-Iko Pharmaceutical Co. Ltd. (Tokyo:4541) acquired. Diagnostics...
BC Week In Review | Dec 14, 2016
Financial News

Microbix financial update

Microbix entered into a secured revolving credit facility for an undisclosed amount from Toronto-Dominion Bank and Export Development Canada. Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario ...
BC Week In Review | Jan 18, 2016
Financial News

Microbix financial update

Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario   Business: Generics, Infectious, Supply/Service   Date announced: 2015-12-31   Note: Microbix secured a new C$200,000 ($141,660) credit facility with two company insiders. The unsecured facility bears 10% interest...
BC Week In Review | Oct 19, 2015
Financial News

Microbix completes private placement of units

Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario   Business: Generics, Infectious, Supply/Service   Date completed: 2015-10-13   Type: Private placement of units   Raised: C$376,000 ($291,174)   Units: 940,000   Price: C$0.40 (unit)   Shares after...
BC Week In Review | Sep 8, 2014
Financial News

Microbix completes private placement of units

Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario   Business: Generics, Infectious, Supply/Service   Date completed: 2014-08-29   Type: Private placement of units   Raised: C$777,731 ($715,979)   Units: 2 million   Price: C$0.39 (unit)   Shares...
BC Week In Review | Sep 1, 2014
Financial News

Microbix completes private placement of units

Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario   Business: Generics, Infectious, Supply/Service   Date completed: 2014-08-22   Type: Private placement of units   Raised: C$1.2 million ($1.1 million)   Units: 3.1 million   Price: C$0.39 (unit)...
BC Week In Review | Mar 3, 2014
Financial News

Microbix completes private placement of convertible debentures and warrants

Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario   Business: Generics, Infectious, Supply/Service   Date completed: 2/20/14   Type: Private placement of convertible debentures and warrants   Raised: C$1.5 million ($1.3 million)   Shares outstanding prior: 66.7...
BC Week In Review | Feb 10, 2014
Company News

Microbix, Novartis infectious news

Microbix said the European Patent Office Tribunal ruled in favor of Microbix in a patent challenge filed by Novartis in 2011 relating to Microbix's Virusmax technology. The tribunal ruled that all patent claims are novel...
BC Week In Review | Feb 11, 2013
Company News

Microbix, Irvine Scientific deal

Microbix sold its purified water-for-injection business to laboratory supplies company Irvine. Microbix said the sale was constructed on an earn-out basis, which uses a pre-agreed formula with variables only to be known in the future,...
BC Week In Review | Dec 3, 2012
Company News

Microbix management update

Microbix Biosystems Inc. (TSX:MBX), Toronto, Ontario   Business: Generics, Infectious, Supply/Service   Hired: Vaughn Embro-Pantalony, a director, as president and CEO; he succeeds William Gastle, who becomes executive chairman   Transitioned: Phil Casselli to SVP...
Items per page:
1 - 10 of 71
BC Extra | Jul 31, 2017
Company News

Management tracks: Aeterna, Microbix, Dimension

Cancer and endocrinology company Aeterna Zentaris Inc. (TSX:AEZS; NASDAQ:AEZS) named Michael Ward CEO. He was chief compliance and legal officer and corporate secretary of Sagent Pharmaceuticals Inc. , which Nichi-Iko Pharmaceutical Co. Ltd. (Tokyo:4541) acquired. Diagnostics...
BC Week In Review | Dec 14, 2016
Financial News

Microbix financial update

Microbix entered into a secured revolving credit facility for an undisclosed amount from Toronto-Dominion Bank and Export Development Canada. Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario ...
BC Week In Review | Jan 18, 2016
Financial News

Microbix financial update

Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario   Business: Generics, Infectious, Supply/Service   Date announced: 2015-12-31   Note: Microbix secured a new C$200,000 ($141,660) credit facility with two company insiders. The unsecured facility bears 10% interest...
BC Week In Review | Oct 19, 2015
Financial News

Microbix completes private placement of units

Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario   Business: Generics, Infectious, Supply/Service   Date completed: 2015-10-13   Type: Private placement of units   Raised: C$376,000 ($291,174)   Units: 940,000   Price: C$0.40 (unit)   Shares after...
BC Week In Review | Sep 8, 2014
Financial News

Microbix completes private placement of units

Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario   Business: Generics, Infectious, Supply/Service   Date completed: 2014-08-29   Type: Private placement of units   Raised: C$777,731 ($715,979)   Units: 2 million   Price: C$0.39 (unit)   Shares...
BC Week In Review | Sep 1, 2014
Financial News

Microbix completes private placement of units

Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario   Business: Generics, Infectious, Supply/Service   Date completed: 2014-08-22   Type: Private placement of units   Raised: C$1.2 million ($1.1 million)   Units: 3.1 million   Price: C$0.39 (unit)...
BC Week In Review | Mar 3, 2014
Financial News

Microbix completes private placement of convertible debentures and warrants

Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario   Business: Generics, Infectious, Supply/Service   Date completed: 2/20/14   Type: Private placement of convertible debentures and warrants   Raised: C$1.5 million ($1.3 million)   Shares outstanding prior: 66.7...
BC Week In Review | Feb 10, 2014
Company News

Microbix, Novartis infectious news

Microbix said the European Patent Office Tribunal ruled in favor of Microbix in a patent challenge filed by Novartis in 2011 relating to Microbix's Virusmax technology. The tribunal ruled that all patent claims are novel...
BC Week In Review | Feb 11, 2013
Company News

Microbix, Irvine Scientific deal

Microbix sold its purified water-for-injection business to laboratory supplies company Irvine. Microbix said the sale was constructed on an earn-out basis, which uses a pre-agreed formula with variables only to be known in the future,...
BC Week In Review | Dec 3, 2012
Company News

Microbix management update

Microbix Biosystems Inc. (TSX:MBX), Toronto, Ontario   Business: Generics, Infectious, Supply/Service   Hired: Vaughn Embro-Pantalony, a director, as president and CEO; he succeeds William Gastle, who becomes executive chairman   Transitioned: Phil Casselli to SVP...
Items per page:
1 - 10 of 71